A patient lies on a scanning table, a helmet studded with ultrasound transducers fitted over their head. There is no ...

Trials on veterans suggest the potent hallucinogen could provide a new treatment for PTSD, but scientists still don't know how it works.

The Food and Drug Administration declined Friday to approve an application to treat post-traumatic stress disorder using the drug midomafetamine, also known as MDMA or the street drug ecstasy, citing ...

A nonbinding Food and Drug Administration panel rejected a proposal to use MDMA, or ecstasy, to treat post-traumatic stress disorder. Lykos Therapeutics and the Multidisciplinary Association for ...

When the U.S. Food and Drug Administration (FDA) last month announced its plans to fast-track the development of psychedelic ...

WASHINGTON — The Department of Veterans Affairs will launch its first clinical study since the 1960s into the effectiveness of psychedelic drugs as a treatment for post-traumatic stress disorder, the ...

About 7% of veterans experience post-traumatic stress disorder (PTSD), and that number can be closer to 30% for those who have served in a war zone. But PTSD has been treated pretty much the same way ...

The Trump administration doesn't plan to reclassify the drug for medical use at this time — it will remain a Schedule I drug.

From spiritual healing to psychedelics to narrative work, recommendations for treating trauma and PTSD are everywhere online. You’ll find them in Instagram reels, wellness podcasts, and posts from ...

Today, I’m writing from the cutting-edge of innovation and research in PTSD. PTSD science continues to advance exponentially, and exciting breakthroughs are on the horizon. What I’m presenting in this ...

A new facility has opened on Nova Scotia's Eastern Shore that was designed specifically to offer support for first responders ...